Skip to content

Clinical trials

Completed Pulmonary Eosinophilia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Status: Completed Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20113
20121
20143
20151
20164
20175
20183
20195
20206
20217
20226
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
GlaxoSmithKline8
Teva Branded Pharmaceutical Products R&D, Inc.4
McMaster University2
Advagene Biopharma Co. Ltd.1
AnaptysBio, Inc.1
Chemlmmune Therapeutics LLC1
Chiesi Farmaceutici S.p.A.1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
General Practitioners Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia50
Asthma30
Airway Obstruction1
Anxiety Disorders1
Chronic Disease1
Churg-Strauss Syndrome1
Disease1
Eosinophilia1
Eosinophilic Esophagitis1
Inflammation1

Trials

Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.